Anaconda Biomed is a Barcelona-based medical technology company developing next-generation thrombectomy catheters for the treatment of ischemic stroke. Its proprietary Funnel Catheter platform combines high-efficiency aspiration with flow arrest and flow reversal to improve clot capture, reduce embolic complications and maximize brain reperfusion, with a portfolio spanning the ANA5, ANA6 and ANA8 funnel catheters and the Conda stent retriever. The company operates its own production facility near Barcelona and is completing the ATHENA pivotal IDE study to support clinical and regulatory requirements in global markets.
1
Round
1
Industry
4
Tags
Sep 23, 2026
Latest raise
Funding activity · 1 round
Sep 23, 2026
$56M
Series B
Led by Omega Funds
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
